Phreesia Inc (PHR)

Official site

HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

$12.63

-0.09 (-0.67%)

Market Cap: $788.92M

Last updated: Nov 06, 2026 at 4:15 PM ET

Earnings

Performance (10Y)

Beat Rate

79%(23/29)

Avg Surprise

-4.78%

Upcoming Estimates

Period ending Oct 31, 2026

EPS Consensus$0.36

Range$0.28 - $0.47

10 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$0.35+0.6%

60d ago$0.36+0.5%

30d ago$0.36-0.4%

7d ago$0.37-2.5%

Current$0.36

Revenue Consensus

$128M

Range$126M - $132M

17 analysts

Period ending Jan 31, 2027

EPS Consensus$0.30

Range$0.15 - $0.72

10 analysts

Revenue Consensus

$128M

Range$123M - $133M

17 analysts

Last 12 of 30 reported quarters and 2 upcoming estimates

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jan 31, 2027Jan 27EST	-	$0.30	$0.15 - $0.72	-	-	10	-	-
Oct 31, 2026Oct 26EST	-	$0.36	$0.28 - $0.47	-	-	10	1 1 30d	-
Jul 31, 2026Jul 26 Reported Sep 2, 2026Reported Sep 2	$0.03	N/A	-	-72.73%	Miss	10	0 1 30d	-88.9%
Apr 30, 2026Apr 26 Reported May 27, 2026Reported May 27	$0.19	$0.29	$0.21 - $0.38	-34.48%	Miss	10	1 2 30d	-15.9%
Jan 31, 2026Jan 26 Reported Mar 30, 2026Reported Mar 30	$0.44	$0.06	$-0.01 - $0.13	+617.26%	Beat	11	0 1 30d	+500.4%
Oct 31, 2025Oct 25 Reported Dec 8, 2025Reported Dec 8	$0.31	$0.24	$0.22 - $0.29	+29.17%	Beat	8	No revisions (30d)	+675.0%
Jul 31, 2025Jul 25 Reported Sep 4, 2025Reported Sep 4	$0.27	$0.19	$0.17 - $0.22	+42.11%	Beat	7	4 1 30d	+1000.0%
Apr 30, 2025Apr 25 Reported May 28, 2025Reported May 28	$0.23	$-0.42	$-0.45 - $-0.40	+153.79%	Beat	7	3 0 30d	+551.8%
Jan 31, 2025Jan 25 Reported Mar 12, 2025Reported Mar 12	$-0.11	$-0.19	$-0.25 - $-0.16	+42.11%	Beat	8	7 0 30d	+47.6%
Oct 31, 2024Oct 24 Reported Dec 9, 2024Reported Dec 9	$0.04	$0.01	$0.00 - $0.02	+300.00%	Beat	7	1 0 30d	+116.0%
Jul 31, 2024Jul 24 Reported Sep 4, 2024Reported Sep 4	$-0.03	$-0.06	-	+50.00%	Beat	12	No revisions (30d)	+91.2%
Apr 30, 2024Apr 24 Reported May 30, 2024Reported May 30	$-0.05	N/A	-	+68.75%	Beat	12	0 1 30d	+86.8%
Jan 31, 2024Jan 24 Reported Mar 14, 2024Reported Mar 14	$-0.21	$-0.26	$-0.29 - $-0.24	+19.23%	Beat	8	No revisions (30d)	+51.2%
Oct 31, 2023Oct 23 Reported Dec 5, 2023Reported Dec 5	$-0.25	$-0.36	$-0.40 - $-0.33	+30.56%	Beat	7	No revisions (30d)	+47.9%

Key Metrics

Valuation
P/E Ratio	13.01	EV/EBITDA	N/A
Price/FCF	11.57x	FCF Yield	8.64%
Profitability
Profit Margin	2.06%	Operating Margin	5.88%
ROE	3.12%	ROIC	2.72%
Financial Health
Debt/Equity	0.18x	Interest Coverage	N/A
Current Ratio	1.76x	Quick Ratio	1.76x
Trading Statistics
Beta	0.72	Avg Volume	667.57K
52-Week High	$23.30	52-Week Low	$7.77

Technical Indicators Dashboard

Moving Averages

SMA 10$12.54

SMA 20$12.03

SMA 50$11.13

SMA 200$10.84

EMA 10$12.49

EMA 20$12.09

EMA 50$11.48

EMA 200$12.46

MACD

Line: 0.50Signal: 0.48Hist: 0.02

ADX

ADX: 35.6+DI: 30.2-DI: 13.4

Aroon & PSAR

Aroon Up96.0

Aroon DownN/A

PSAR$12.02

Bollinger Bands

Upper Band$13.62

Lower Band$10.44

%B Position2648%(Upper)

Band Width0.69

RSI (14-Day)

Neutral

61.5

Momentum Oscillators

Stoch %K77.7

Stoch %D80.6

Williams %R-36.4

ROC (10d)-0.6%

Momentum-0.07

CCI (20d)50.7

MFI (14d)67.6

Volatility Measures

ATR (14d)$0.52(4.1%)

StdDev (20d)0.80

Hist Vol46.5%(High)

Volume Flow

VWAP$12.51

OBV1.3M

AD Line744.4K

CMF (20d)0.275

Volume Metrics

Avg Vol (20d)672.7K

Vol Ratio1.0x

VWMA (20d)$12.03

Pivot Points

R3$14.11

R2$13.75

R1$13.23

Pivot Point$12.87

S1$12.35

S2$11.99

S3$11.47

Advanced Oscillators

TSI32.06

Ultimate Osc60.5

KST195.33

Financial Data

Quarter	Jul 2026	Apr 2026	Jan 2026	Oct 2025	Jul 2025	Apr 2025	Jan 2025	Oct 2024	Jul 2024	Apr 2024	Jan 2024	Oct 2023
Total Revenue	$129.46M	$130.94M	$127.07M	$120.33M	$117.25M	$115.94M	$109.68M	$106.80M	$102.11M	$101.22M	$95.00M	$91.62M
Cost of Revenue	$19.27M	$17.66M	$-42,368,000	$38.03M	$17.40M	$16.64M	$-35,141,000	$34.54M	$32.81M	$34.02M	$-31,212,000	$30.94M
Gross Profit	$110.19M	$113.28M	$169.44M	$82.31M	$99.86M	$99.30M	$144.82M	$72.26M	$69.30M	$67.20M	$126.22M	$60.68M

Operating Expenses	$102.58M	$106.53M	$174.99M	$78.57M	$101.36M	$102.59M	$152.43M	$86.11M	$86.53M	$86.62M	$155.79M	$92.72M
R&D	$27.57M	$28.33M	$30.93M	$29.45M	$29.27M	$31.83M	$29.63M	$29.32M	$29.54M	$28.88M	$29.86M	$28.54M
SG&A	$16.51M	$18.36M	$26.96M	$17.49M	$19.04M	$16.41M	$18.41M	$19.63M	$19.50M	$19.05M	$18.82M	$20.24M
Operating Income	$7.61M	$6.75M	$-5,557,000	$3.74M	$-1,507,000	$-3,287,000	$-7,612,000	$-13,843,000	$-17,222,000	$-19,420,000	$-29,578,000	$-32,045,000

Interest Income	$248,000	$297,000	$1.42M	$380,000	$999,000	$205,000	$2.37M	$26,000	$46,000	$239,000	$2.04M	$523,000
Interest Expense	$1.73M	$2.32M	$4.77M	$0	$391,000	$435,000	$0	$118,000	$40,000	$0	$851,000	$0
Income Before Tax	$3.24M	$4.72M	$-10,323,000	$5.13M	$-563,000	$-3,179,000	$-5,376,000	$-13,961,000	$-17,262,000	$-19,212,000	$-30,429,000	$-31,569,000
Income Tax Expense	$1.32M	$1.76M	$-11,618,000	$854,000	$-1,217,000	$735,000	$1.01M	$442,000	$750,000	$510,000	$217,000	$372,000

Net Income	$1.92M	$2.96M	$1.29M	$4.27M	$654,000	$-3,914,000	$-6,390,000	$-14,403,000	$-18,012,000	$-19,722,000	$-30,646,000	$-31,941,000

EBITDA	$14.96M	$17.25M	$8.30M	$12.39M	$6.54M	$4.10M	$1.60M	$-5,516,000	$-9,762,000	$-12,525,000	$-20,973,000	$-24,310,000
EBIT	$4.72M	$6.74M	$-4,284,000	$4.75M	$-1,171,000	$-2,949,000	$-5,395,000	$-13,987,000	$-17,308,000	$-19,451,000	$-29,495,000	$-32,092,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about PHR

News

Phreesia Sets Release Date for Fiscal Third Quarter 2027 Results

Phreesia, Inc. (NYSE: PHR) announced it will release its fiscal third quarter 2027 financial results after market close on Wednesday, Dec. 2...

01net•Nov 5, 2026 7:40 PM ET11/5/26•Neutral

A 502-unit stock award replaces a cash retainer for Phreesia (PHR) director Gillian Munson.

Phreesia director Gillian Munson received 502 deferred stock units (DSUs) on October 30, 2026, valued at $12.44 per share...

Stock Titan•Nov 3, 2026 7:39 AM ET11/3/26•Neutral

Phreesia Director Lainie Goldstein Acquires 502 Deferred Stock Units in Quarterly Retainer Election

Phreesia, Inc. Director Lainie Goldstein acquired 502 deferred stock units (DSUs) in Phreesia, Inc. (NYSE:PHR) on October 30, 2026...

Kalkine Media•Nov 2, 2026 5:11 PM ET11/2/26•Somewhat-Bullish

Phreesia, Inc. (PHR) Seasonal returns chart - Yahoo Finance

This Yahoo Finance article presents a seasonal returns chart for Phreesia, Inc. (PHR), showing the average monthly price return for the period between 2019 and 2026. The article also includes current stock information...

Yahoo Finance Singapore•Oct 31, 2026 6:42 PM ET10/31/26•Neutral

Phreesia's Q2 revenue rises 10.4%, but subscription dips; full-year profit target depends on network solutions growth.

Phreesia reported a 10.4% year-over-year revenue increase to $129.5 million in Q2, primarily driven by payment solutions growth after the AccessOne acquisition. Despite this, subscription revenue declined...

Pluang•Oct 31, 2026 5:30 AM ET10/31/26•Neutral

PHR Valuation and Fair Value

P/E: 13.0x
Forward P/E: 14.8x
P/FCF: 11.6x
P/B: 2.1x

See GNG's fair value

PHR Profitability: Margins, ROIC and FCF

Gross margin: 93.6%
Operating margin: 5.9%
Net margin: 2.1%
ROIC: 2.7%
ROE: 3.1%
FCF yield: 8.6%

PHR Competitors

Company	Ticker
Esperion Therapeutics Inc	ESPR
Varex Imaging Corp	VREX
Prime Medicine, Inc. Common Stock	PRME
Ginkgo Bioworks Holdings	DNA
Beta Bionics, Inc. Common Stock	BBNX
InMode Ltd	INMD
Rigel Pharmaceuticals Inc	RIGL
Collegium Pharmaceutical Inc	COLL

Sector: Healthcare

PHR Analyst Ratings

Consensus: Buy
Analysts: 18
Strong Buy: 2
Buy: 8
Hold: 8
Sell: 0
Strong Sell: 0

PHR Bull Case vs Bear Case

Bull case

PHR beat EPS estimates in 75.0% of its last 8 reported quarters.
PHR grew quarterly revenue 10.4% year over year.

PHR Earnings: Beat Rate and Next Report

Beat rate: 6 of 8 quarters (75.0%)
Average surprise: 134.7%
EPS estimate (fiscal period ending Oct 31, 2026): $0.36
Estimate revisions (30 days, fiscal period ending Oct 31, 2026): 1 up, 1 down

PHR Earnings Date

PHR reports Dec 7, 2026. The date is estimated.

PHR Earnings Call

The latest PHR earnings call transcript on file is labeled 2026Q3.

Read the 2026Q3 transcript

PHR ETF Holders

GNG tracks 9 ETFs that hold PHR. The largest weights:

VictoryShares Small Cap Free Cash Flow ETF (SFLO), 0.20% of the fund
Fidelity Enhanced Small Cap Core ETF (FESM), 0.08% of the fund
iShares Russell 2000 ETF (IWM), 0.05% of the fund
Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.04% of the fund
Vanguard Extended Market Index Fund ETF Shares (VXF), 0.02% of the fund

Open the ETF Stock Exposure tool for PHR

See insider activity

Frequently Asked Questions About PHR

When does PHR report earnings?

Phreesia Inc (PHR) is expected to report earnings on Dec 7, 2026.

Does PHR pay dividends?

Phreesia Inc (PHR) does not currently pay a regular dividend.

What is PHR's P/E ratio?

Phreesia Inc has a price-to-earnings (P/E) ratio of 13.01.

What is PHR's market cap?

Phreesia Inc (PHR) has a market capitalization of $788.92M with a current stock price of $12.63.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In